» Articles » PMID: 26067490

Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response

Overview
Journal PLoS One
Date 2015 Jun 13
PMID 26067490
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mutations in LRRK2 are related to certain forms of Parkinson's disease and, possibly, to the pathogenesis of Crohn's disease. In both these diseases inflammatory processes participate in the pathogenic process. LRRK2 is expressed in lymphoid cells and, interestingly, Lrrk2 (-/-) mice were reported to develop more severe experimental colitis than their wild type (WT) controls. Here, we examined the possible involvement of LRRK2 in the pathogenesis of experimental autoimmune uveitis (EAU), an animal model for human uveitis, by testing Lrrk2 (-/-) mice for their capacity to develop this experimental eye disease and related immune responses.

Methods: Lrrk2 (-/-) mice and their WT controls (C57Bl/6) were immunized with interphotoreceptor retinoid-binding protein (IRBP) and compared for their development of EAU, delayed type hypersensitivity (DTH) by skin tests, production of cytokines in culture, and expression of interferon (IFN)-γ, interleukin (IL)-17 and FoxP3 by spleen cells, using flow cytometry. Peritoneal macrophages were examined for their production of cytokines/chemokines in culture following stimulation with LPS or the oligodeoxynucleotide CpG. The Lrrk2 (-/-) and WT mice were also compared for their response to bovine serum albumin (BSA).

Results: The Lrrk2 (-/-) mice developed lower levels of EAU, DTH responses and cytokine production by lymphocytes than did their WT controls. Intracellular expression of IFN-γ and IL-17, by spleen cells, and secretion of cytokines/chemokines by activated peritoneal macrophages of Lrrk2 (-/-) mice trended toward diminished levels, although variabilities were noted. The expression levels of FoxP3 by Lrrk2 (-/-) spleen cells, however, were similar to those seen in WT controls. Consistent with their low response to IRBP, Lrrk2 (-/-) mice responded to BSA less vigorously than their WT controls.

Conclusions: Lrrk2 deficiency in mice diminished the development of EAU and the related adaptive immune responses to IRBP as compared to the WT controls.

Citing Articles

Role of leucine-rich repeat kinase 2 in severe acute pancreatitis.

Otsuka Y, Minaga K, Kudo M, Watanabe T Front Immunol. 2024; 15:1364839.

PMID: 38440723 PMC: 10910022. DOI: 10.3389/fimmu.2024.1364839.


Leucine-rich repeat kinase 2 promotes the development of experimental severe acute pancreatitis.

Otsuka Y, Hara A, Minaga K, Sekai I, Kurimoto M, Masuta Y Clin Exp Immunol. 2023; 214(2):182-196.

PMID: 37847786 PMC: 10714192. DOI: 10.1093/cei/uxad106.


Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson's Disease.

Peter I, Strober W J Parkinsons Dis. 2023; 13(3):279-296.

PMID: 37066923 PMC: 10200211. DOI: 10.3233/JPD-230021.


Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells.

Nazish I, Arber C, Piers T, Warner T, Hardy J, Lewis P Neurochem Int. 2021; 147:105070.

PMID: 34004238 PMC: 7610942. DOI: 10.1016/j.neuint.2021.105070.


Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune Uveitis.

Xu B, Tang J, Lyu C, Wandu W, Stumpo D, Mattapallil M Front Immunol. 2021; 11:583510.

PMID: 33569048 PMC: 7868398. DOI: 10.3389/fimmu.2020.583510.


References
1.
Vistica B, Shi G, Nugent L, Tan C, Altman A, Gery I . SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU). Mol Vis. 2012; 18:1858-64. PMC: 3398495. View

2.
Luger D, Silver P, Tang J, Cua D, Chen Z, Iwakura Y . Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008; 205(4):799-810. PMC: 2292220. DOI: 10.1084/jem.20071258. View

3.
Dzamko N, Halliday G . An emerging role for LRRK2 in the immune system. Biochem Soc Trans. 2012; 40(5):1134-9. DOI: 10.1042/BST20120119. View

4.
Forrester J, Klaska I, Yu T, Kuffova L . Uveitis in mouse and man. Int Rev Immunol. 2013; 32(1):76-96. DOI: 10.3109/08830185.2012.747524. View

5.
Shi G, Vistica B, Nugent L, Tan C, Wawrousek E, Klinman D . Differential involvement of Th1 and Th17 in pathogenic autoimmune processes triggered by different TLR ligands. J Immunol. 2013; 191(1):415-23. PMC: 3749791. DOI: 10.4049/jimmunol.1201732. View